Stocks Hitting 52-Week Lows

Spectrum Pharmaceuticals

shares touched a new 52-week low of $6.95. Spectrum Pharmaceuticals shares have dropped 45.28% over the past 52 weeks, while the S&P 500 index has gained 10.16% in the same period. Rockwell Medical

shares dropped 7.43% to reach a new 52-week low of $3.24. Rockwell Medical entered into definitive agreements to sell 4,300,000 common shares at $3.00 per share in a registered direct offering. BioLineRx

shares touched a new 52-week low of $1.85. BioLineRx reported that results from an interim analysis of the Phase II/III CLARITY trial of BL-1020 for the treatment of schizophrenia, indicate that the trial would not meet the pre-specified primary efficacy endpoint. Chesapeake Granite Wash Trust

shares dipped 15.62% to reach a new 52-week low of $14.31. Chesapeake Granite Wash Trust's trailing-twelve-month ROA is 16.84%.